Image Analysis

Hørsholm, Denmark -- Today, the Market Development Fund, announced that it will support Visiopharm’s validation of its novel solutions for cancer diagnostics at seven Danish Hospitals and three international Hospitals. Visiopharm’s...

</body> PathXL will be exhibiting at Pathology Informatics Pittsburgh, PA from Tuesday May 13th – Friday May 16th. PathXL invite you to join us at table #12 where you can meet our Sales and Business Development Director North...

</body> Date: Thursday May 15th Time: 4:00 pm GMT (UK) | 11:00 am EST PathXL’s proprietary tumor detection software, TissueMark®, has been evolving rapidly since its launch in November 2013 and we are glad to announce a range of...

Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date:     Monday,...

Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology Boulder, CO - April 30, 2014 - Flagship Biosciences announces it has reached agreement with Leica...

OR

platinum partners

gold partners

Silver Partners

Media Partners